E, R., R, T., E, L., A, G., C, J., O, M., . . . JF, V. (2023). Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months. British journal of haematology, 202(1), 159. https://doi.org/10.1111/bjh.18818
Chicago Style (17th ed.) CitationE, Rivière, Thiébaut R, Lazaro E, Guy A, James C, Mansier O, Blanco P, and Viallard JF. "Assessment of Circulating Blood Lymphocytes in Adult Patients on Rituximab to Treat Immune Thrombocytopenia: Circulating Number of NK Cells Is Associated with the Response at 6 months." British Journal of Haematology 202, no. 1 (2023): 159. https://doi.org/10.1111/bjh.18818.
MLA (9th ed.) CitationE, Rivière, et al. "Assessment of Circulating Blood Lymphocytes in Adult Patients on Rituximab to Treat Immune Thrombocytopenia: Circulating Number of NK Cells Is Associated with the Response at 6 months." British Journal of Haematology, vol. 202, no. 1, 2023, p. 159, https://doi.org/10.1111/bjh.18818.
